021: Prospective genetic characterization of tumors from individual patients of special interest

HIPO Investigator:

Prof. Hanno Glimm

Dr. Christof Heining

Dr. Stefan Fröhling

Supported by: NCT-POP and DKFZ-HIPO

Entitiy: various


Chudasama P. et al.; Integrative genomic and transcriptomic analysis of leiomyosarcoma; Nat. Commun 2018 (together with H028 and H018)

Czink E et al.; Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer; Cold Spring Harb Mol Case Stud. 2017

Gröschel S et al.; Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification; Cold Spring Harb Mol Case Stud. 2017

Horak P et al. ; Precision oncology based on omics data: The NCT Heidelberg experience; Int J Cancer 2017

Drennan S et al.; IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus; Leukemia 2017

Chudasama P et al.; Targeting fibroblast growth factor receptor 1 for treatment of soft-tissue sarcoma; Clin Cancer Res 2017

Dieter SM et al.; Mutant KIT as Imatinib-Sensitive Target in Metastatic Sinonasal Carcinoma; Ann Oncol 2017

Czink E et al.; Durable remission under dual HER2 blockade with trastuzumab and pertuzumab in a patient with metastatic gallbladder cancer; Z Gastroenterol 2016

Bochtler T. et al.; Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia; Cold Spring Harb Mol Case Stud 2016

Kordes M et al.; Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling; Leukemia 2016

Yaktapour N et al.; BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia; J Clin Invest 2014

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.